News
Elon Musk’s Neuralink brain-machine interface is turning sci-fi into reality
Besides giving the world the option to switch to Tesla emissions-free electric cars and hopes of sending humans to Mars and beyond, Elon Musk also dreams of giving humans symbiosis with artificial intelligence through an implantable brain-machine interface created by Neuralink, a company he founded in 2016.
Neuralink is working on improving the basic structures of high-density Utah Array, a tiny chip that has become the industry benchmark for recording large populations of neurons. Dr. Richard Norman from the University of Utah invented the chip in 1997, which acts as an ultra-thin, flexible, and biocompatible polymer that connects the human brain to a tiny chip. During an event last year, Neurallink explained that the implant can be placed behind the ear and can interpret brain signals. Musk’s neural tech company has also invented a robot that can sew the implant to the brain with better precision than any human surgeon.
Wait until you see the next version vs what was presented last year. It’s *awesome*.
— Elon Musk (@elonmusk) February 3, 2020
So far, the brain-machine interface by Neuralink has reportedly helped a primate communicate with a computer interface. There are plans to install a prototype this year into a human. According to Musk, they are still on track to do this.
“It will ultimately be used to make up for entire lost sections of the brain due to stroke/accident/congenital. Don’t want to get too excited, but the potential is truly transformational for restoring brain & motor functions. There is no other way to do it imo,” Musk also wrote on Twitter.
The possibilities for Neuralink’s implant are endless. The symbiosis between humans and AI will be a long shot but Neuralink’s implantable device can pave the way for medical advancements that can help people with chronic neurological problems. Possible medical uses for Neuralink’s device in the future include controlling devices, restoring sensation, and synthetic speech.
CONTROLLING DEVICES
The brain is a complex network of nerves that uses impulses to sense the outside world and to control the human body. Neuralink will use these signals and amplify them so a patient can use them to be more functional. For example, someone with paralyzed upper extremity due to a stroke can have a brain-machine interface on the center of the brain that controls movements of the arm and hands which will help patients feed, dress, and generally function on their own.
Likewise, for someone who has an amputated limb, the Neuralink brain-machine interface will be able to communicate with a robotic arm to help someone use an artificial hand to write or use a computer. It can also be perfect for someone who needs to control a robotic leg to prop one up to stand without the help of anyone.
With a smart home setup, a paralyzed person who cannot clearly or is unable to speak and move can simply command a computer to dim the lights, turn on the air conditioner, or call someone if they need urgent attention.
While it might be a very long shot, these brain-machine interfaces interacting with other future technologies can also serve as bridges to parts of the body that are medically “disconnected”. For example, a patient with spinal cord injury has severed connections between the brain and parts of their body corresponding to the level their spinal cord was injured. The Neuralink implant can play pseudo stem cells that will provide the artificial connection so one can better function. Same for someone with multiple sclerosis whose nerves basically lose the sheath that makes them transmit electrical signals optimally.
“RESTORE” SENSATION
Just like how Neuralink can be exploited to help the brain control movement of a robotic arm, it is highly possible to tap into the sensory cortex of the brain. Sensation allows better manipulation of one’s environment and should be very helpful even when using robotic arms. One can tap the signals of the brain, send it to the brain-machine implant and to the robotic hand, for example, and back. If one grabs a glass of water, it can easily control the movement through space because the patient knows its shape, weight, texture, temperature, among other factors.
The Neuralink team also aims to use the brain-machine interface to “give back” one’s vision by tapping into the visual center of the brain.
SYNTHETIC SPEECH
With its ability to tap into specific signals of the brain, Neuralink also has the potential to create synthetic speech for people who are paralyzed or those with neurological conditions that do not allow them to speak.
These are just some of the things we can see Neuralink will be used for in the future. While all these seem to be fantastical, according to Neuralink, what they’re doing is not pulled from thin air but based on decades of neurological foundation.
Ultimately, with the dream of human-AI symbiosis, as more technologies develop, the use for Neuralink’s brain-machine implant will evolve. Elon Musk mentioned before that perhaps one day, it will be used for telepathic communication between humans or perhaps even drive a Tesla. Or perhaps, in the future, one can upgrade one’s knowledge and download terabytes of information with a blink of an eye through Starlink.
Investor's Corner
Tesla and SpaceX take “Terafab” Trademark fight to Federal Court
Tesla and SpaceX sue a small Illinois firm after cease and desist letters over Terafab.
Tesla and SpaceX are asking a federal judge to rule that their planned Terafab chip factory does not infringe a small Illinois company’s trademark, a request that arrives only after months of quiet negotiation broke down this summer.
The dispute traces to May 18, when Tesla filed three U.S. trademark applications for “Terafab” and “Tesla Terafab,” covering semiconductor chips and related chip making services. TERA-print LLC, a nanotechnology company that has held a federal trademark for “Tera-Fab” since 2021, responded five days later with a cease and desist letter. According to the lawsuit, first reported by Reuters, TERA-print argued that Tesla and SpaceX’s use of “Terafab” would confuse consumers familiar with its own trademark, which covers a desktop photolithography printer sold to researchers for sensor and bioengineering work.
What stands out in the filing is the timing of TERA-print’s own paperwork. One day before sending that cease and desist letter, on May 22, TERA-print applied to expand its existing registration to cover semiconductor materials, silicon chips, nanoelectronic devices and AI design services, categories it had not previously claimed. Tesla and SpaceX call that filing opportunistic in their complaint, noting it arrived two months after Tesla’s public Terafab announcement and just days after Tesla’s own trademark applications went in.
Elon Musk launches TERAFAB: The $25B Tesla-SpaceXAI chip factory that will rewire the AI industry
By June 10, TERA-print was threatening to sue for federal trademark infringement, false designation of origin and unfair competition, the complaint states. Rather than wait to be sued, Tesla, SpaceX and SpaceXAI met with TERA-print six separate times between June and August trying to resolve the dispute directly. Those talks collapsed, and the companies filed for declaratory judgment this week in the U.S. District Court for the Western District of Texas, asking a judge to find that “Terafab” does not infringe TERA-print’s mark before TERA-print can file a claim of its own.
TERA-print isn’t backing down. The company told PCMag it discussed a settlement with Tesla as recently as September 2 and feels misled by what it called Tesla’s professed interest in settling. Its CTO, Andrey Ivankin, said TERA-print holds a Defense Department contract to fabricate semiconductors and partially owns Mattiq Inc., an AI company built on TERA-print’s products, and that the company will vigorously defend its rights.
Tesla and SpaceX argue the overlap is superficial. Terafab is planned as a $16.8 billion complex spanning roughly 100 million square feet at the Grimes County site SpaceX confirmed last month, built to produce chips for Optimus robots, Tesla’s AI computing needs and SpaceX’s orbital data center ambitions, a scale and purpose the companies say no reasonable consumer would confuse with a tabletop lab printer. TERA-print’s product line has stayed focused on lithography tools for biological and sensor research since it registered its mark in 2021.
The trademark fight is the second legal dispute tied to the Terafab project in the past week, following a separate SpaceX suit aimed at keeping company records about the facility out of public view, as KBTX reported. Whether construction proceeds under the Terafab name now depends on a federal judge in Austin.
News
NHTSA just escalated its Tesla Cybercab investigation in a big way
NHTSA escalated its Cybercab audit into a sworn Special Order with a September 30 deadline.
Federal regulators have moved from asking Tesla questions about its Cybercab to demanding sworn answers. The National Highway Traffic Safety Administration issued a Special Order that requires a Tesla officer to sign an affidavit attesting to the completeness of the company’s responses, with a deadline of September 30.
The order builds on Audit Query AQ26002, which NHTSA opened on September 3, the same day Tesla began commercial Cybercab service in Austin. Teslarati covered that initial inquiry when it surfaced, noting the agency wanted to understand how Tesla certified a vehicle with no permanently attached steering wheel, pedals, or mirrors as compliant with Federal Motor Vehicle Safety Standards. A Special Order is a different tool and converts a fact finding review into a legally enforceable demand, the same mechanism NHTSA used against Tesla in 2023 during its Autopilot investigation.
Several of the 21 requests target a specific gap in Cybercab’s design. One asks whether Tesla used temporarily attached human controls at any point to help certify the vehicle, and if so, which standards depended on that equipment being present. Another quotes an existing rule directly: “The service brakes shall be activated by means of a foot control.” Cybercab has no foot pedal. NHTSA wants a detailed explanation of how the vehicle satisfies that requirement, and how it complies without the kind of exemption granted to Zoox in July under Part 555, the regulatory pathway built for steering wheel free vehicles.
The order does not claim Cybercab is unsafe or that Tesla broke a rule. It requires Tesla to explain, under oath, the reasoning behind decisions the company already made when it self-certified the vehicle. That distinction matters, but so does the exposure. Motor1’s reporting, summarized here, put potential civil penalty exposure as high as $139 million if NHTSA later finds the certification was flawed, on top of whatever criminal risk comes with a false sworn statement.
Tesla has not said publicly how it plans to respond. Cybercab is still carrying passengers in Austin through the Robotaxi app while the September 30 deadline approaches, and the company has continued expanding the vehicle’s footprint even as the regulatory question remains open. The Special Order does not pause any of that and just sets a date by which Tesla has to put its certification logic on the record, with a company officer’s name attached to it.
In a new interview on Wednesday, Tesla uber bull Ron Baron said that anyone looking to buy the company’s stock should do so as soon as they can.
Baron, founder and CEO of Baron Capital and one of Tesla’s most persistent institutional bulls, used a CNBC Squawk Box appearance on Wednesday to deliver a familiar message with fresh urgency: In his opinion, Tesla stock is a buy:
“The time to buy the stock is now. FSD is catching on, and it’s going to be bigger and bigger. 55% of new buyers are buying it (Teslas) with FSD. It’s going to be everywhere. It’s safer.”
The Baron Capital frontman’s case is built around Full Self-Driving. Tesla reported 1.48 million active FSD subscriptions in the second quarter, up 56 percent year over year, and company officials have said roughly 55 percent of new North American deliveries left with a subscription enabled.
Baron framed that attach rate as proof the product is moving from enthusiast extra to default expectation, and as a reason software, not just vehicle volume, should drive the next phase of value.
His conviction on Tesla shares is not theoretical, as Baron Capital made its first Tesla investment in 2014, after years of meetings that began around the 2010 IPO roadshow. The firm later built a large SpaceX position starting in 2017.
Ron Baron today in new interview on Tesla:
“The time to buy the stock is now. FSD is catching on, and it’s going to be bigger and bigger. 55% of new buyers are buying it (Teslas) with FSD. It’s going to be everywhere. It’s safer.” pic.twitter.com/Rv5PB0bVZ2
— Sawyer Merritt (@SawyerMerritt) September 16, 2026
Baron said those Musk-led bets have generated about $30 billion of the $71 billion in profits Baron Capital has produced for clients. He put the firm’s current exposure at roughly $25 billion in SpaceX and $5 billion in Tesla. Personally, he described SpaceX as his largest holding, at about $5 billion, with about $1.5 billion in Tesla and additional Tesla exposure through the firm’s funds.
That concentration is also a statement of loyalty. Asked about talk of a SpaceX-Tesla combination, Baron said he had already walked Elon Musk through arguments for and against a deal, then declined to repeat them on air. His public position was simpler: “Whatever you decide is better is what I’m going to support,” he said to Musk.
Baron also said that he picked up the farewell edition of the Model S after Tesla decided to sunset the vehicle earlier this year, calling it his favorite car he’s ever driven.
Tesla and SpaceX take “Terafab” Trademark fight to Federal Court
NHTSA just escalated its Tesla Cybercab investigation in a big way
